These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 19421058)

  • 41. [Serogroup W135 meningococcal meningitis epidemic in 2000 and 2001].
    Nicolas P
    Med Trop (Mars); 2001; 61(3):259-61. PubMed ID: 11582892
    [No Abstract]   [Full Text] [Related]  

  • 42. Meningococcal vaccine: New product, new recommendations.
    Campos-Outcalt D
    J Fam Pract; 2005 Apr; 54(4):324-6. PubMed ID: 15833222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand.
    Lennon D; Jackson C; Wong S; Horsfall M; Stewart J; Reid S
    Clin Infect Dis; 2009 Aug; 49(4):597-605. PubMed ID: 19622040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM;
    Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II meningococcal B vesicle vaccine trial in New Zealand infants.
    Jackson C; Lennon DR; Sotutu VT; Yan J; Stewart JM; Reid S; Crengle S; Oster P; Ypma E; Aaberge I; Mulholland K; Martin DR
    Arch Dis Child; 2009 Oct; 94(10):745-51. PubMed ID: 18838420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Challenges and progress in the development of a serogroup B meningococcal vaccine.
    Lewis S; Sadarangani M; Hoe JC; Pollard AJ
    Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual cluster of mild invasive serogroup C meningococcal infection in a university college.
    Ferson M; Young L; Hansen G; Post J; Tapsall J; Shultz T; Limnios A; Lee D; Reinbott P; Duffy Y; Robertson P; Jones P; Pontivivo G; Morgan K
    Commun Dis Intell; 1999 Sep; 23(10):261-4. PubMed ID: 10581818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rates of Neisseria meningitidis increasing in young adults.
    Gaur S; Malhotra A; Whitley-Williams P
    Pediatr Ann; 2004 Sep; 33(9):590-5. PubMed ID: 15462574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 51. Routinely vaccinating adolescents against meningococcus: targeting transmission & disease.
    Vetter V; Baxter R; Denizer G; Sáfadi MA; Silfverdal SA; Vyse A; Borrow R
    Expert Rev Vaccines; 2016 May; 15(5):641-58. PubMed ID: 26651380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Which vaccination strategies for African meningococcal meningitis?].
    Saliou P; Debois H
    Bull Soc Pathol Exot; 2002 Dec; 95(5):326-30. PubMed ID: 12696369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
    Trotter CL; Ramsay ME
    FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine offers meningitis hope.
    Butler D
    Nature; 2010 Nov; 468(7321):143. PubMed ID: 21068797
    [No Abstract]   [Full Text] [Related]  

  • 55. Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy.
    Mastrantonio P; Stefanelli P; Fazio C; Sofia T; Neri A; La Rosa G; Marianelli C; Muscillo M; Caporali MG; Salmaso S
    Clin Infect Dis; 2003 Feb; 36(4):422-8. PubMed ID: 12567299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new conjugate meningococcal vaccine (Menveo).
    Med Lett Drugs Ther; 2010 Jul; 52(1343):59-60. PubMed ID: 20651639
    [No Abstract]   [Full Text] [Related]  

  • 57. First case of meningococcal meningitis due to Neisseria meningitidis serogroup Z' in Slovenia, December 2010.
    Trop Skaza A; Selic Kurincic T; Beskovnik L; Paragi M; Bozanic V
    Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.